Skip to content
10-Q

Quarterly Report

Elevance Health, Inc. ELV

0001156039-26-000043

← back to feed
Filed
Apr 22, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 15, 2026 217.16M sh
Shares Diluted Q1 2026 · Mar 31, 2026 220.4M sh
Shares Diluted Q1 2026 · Mar 31, 2025 227.2M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $1.12B
Stock Repurchased Q1 2026 · Mar 31, 2025 $880M
Dividends Paid Q1 2026 · Mar 31, 2026 $376M
Dividends Paid Q1 2026 · Sep 30, 2025 $376M
Dividends Paid Q1 2026 · Mar 31, 2025 $386M
Dividends Paid Q1 2026 · Sep 30, 2024 $386M
Capex Q1 2026 · Mar 31, 2026 $235M
Capex Q1 2026 · Mar 31, 2025 $196M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $4.33B
Operating Cash Flow Q1 2026 · Mar 31, 2025 $1.02B
Long Term Debt Q1 2026 · Mar 31, 2026 $30.77B
Long Term Debt Q1 2026 · Dec 31, 2025 $30.8B
Short Term Debt Q1 2026 · Mar 31, 2026 $724M
Short Term Debt Q1 2026 · Dec 31, 2025 $150M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $9.66B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $9.49B
Stockholders Equity Q1 2026 · Mar 31, 2026 $43.9B
Stockholders Equity Q1 2026 · Dec 31, 2025 $43.88B
Current Liabilities Q1 2026 · Mar 31, 2026 $45.31B
Current Liabilities Q1 2026 · Dec 31, 2025 $41.04B
Total Liabilities Q1 2026 · Mar 31, 2026 $81.79B
Total Liabilities Q1 2026 · Dec 31, 2025 $77.47B
Current Assets Q1 2026 · Mar 31, 2026 $67.03B
Current Assets Q1 2026 · Dec 31, 2025 $63B
Total Assets Q1 2026 · Mar 31, 2026 $125.83B
Total Assets Q1 2026 · Dec 31, 2025 $121.49B
Eps Diluted Q1 2026 · Mar 31, 2026 $8.00
Eps Diluted Q1 2026 · Mar 31, 2025 $9.61
Eps Basic Q1 2026 · Mar 31, 2026 $8.03
Eps Basic Q1 2026 · Mar 31, 2025 $9.64
Sga Expense Q1 2026 · Mar 31, 2026 $6.33B
Sga Expense Q1 2026 · Mar 31, 2025 $5.3B
Net Income Q1 2026 · Mar 31, 2026 $1.76B
Net Income Q1 2026 · Mar 31, 2025 $2.18B
Operating Income Q1 2026 · Mar 31, 2026 $2.09B
Operating Income Q1 2026 · Mar 31, 2025 $3.17B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $5.46B
Cost Of Revenue Q1 2026 · Mar 31, 2025 $4.98B
Revenue Q1 2026 · Mar 31, 2026 $50.18B
Revenue Q1 2026 · Mar 31, 2025 $48.89B